TEMSIROLIMUS (has an active metabolite) | TEMSIROLIMUS | ATC L01EG01
ANTINEOPLASTIC AGENTS TREATMENT OF ADVANCED RENAL CELL CARCINOMA PROTEIN-PROTEIN INTERACTION INHIBITOR FKBP12 / MTOR (MAMMALIAN TARGET OF RAPAMYCIN) TREATMENT OF MANTLE CELL LYMPHOMA (MCL) (DRUG FOR RARE DISEASE IN EUROPE) | INTRAVENOUS | Cmax 056 MICROMOLAR (25 MILLIGRAM) VD 172 LITER Cl 16.2 LITER / HOUR HT 17.3 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | FK506 BINDING PROTEIN-12 (FKBP-12)/MTOR COMPLEX PDB 7SQ9 (CRYO-EM STRUCTURE OF MOUSE TEMSIROLIMUS, PI(3,5)P2-BOUND TRPML1 CHANNEL AT 2.11 ANGSTROM RESOLUTION) LIGAND CODE = A4I (link to the list of PDB complexes) Download experimental 3D coordinates of A4I with added hydrogens | Peptidyl-prolyl cis-trans isomerase FKBP1A UNIPROT P62942 FKBP1A more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |